Serviços Personalizados
Journal
artigo
Indicadores
Compartilhar
Journal of Human Growth and Development
versão impressa ISSN 0104-1282versão On-line ISSN 2175-3598
Resumo
COLA, João Paulo et al. Factors associated with carrying out molecular tests for the diagnosis of COVID-19 in the State of Espírito Santo, Brazil. J. Hum. Growth Dev. [online]. 2023, vol.33, n.1, pp.113-123. Epub 06-Dez-2024. ISSN 0104-1282. https://doi.org/10.36311/jhgd.v33.13568.
Backgroung
Brazil was slow to implement an expanded testing policy for COVID-19, which may have affected the most vulnerable population’s access to testing services.
Objective
to evaluate the factors associated with performing the molecular test for COVID-19.
Methods
cross-sectional study of secondary data from the COVID-19 panel in the state of Espírito Santo. COVID-19 suspicion notification forms were included between September 11, 2020 and March 2, 2021. Hierarchical logistic regression was used to estimate the odds ratio (OR) with 95% confidence interval (CI95%).
Results
419,771 notification forms were analyzed. The prevalence of performing the molecular teste for COVID-19 was 81.1% (CI95% 81.0-81.2). Elderly (OR= 2.70 – CI95% 2.56-2.85), health professional (OR=1 .43 – CI95% 1.36-1.50), chronic cardiovascular disease (OR=1.13 – CI95% 1.09-1.17), diabetes mellitus (OR=1.07 – CI95% 1.01- 1.14) and hospitalization (OR=5.95 – CI95% 4.53;7.82) were more likely to have undergone the molecular test. Male sex (OR=0.96 – CI95% 0.94-0.98), black skin color (OR=0.75 – CI95% 0.73-0.78), yellow skin color (OR=0.74 – CI95% 0.71-0.77), residing in the northern health region (OR=0.37 – CI95% 0.36-0.39) and the homeless population (OR=0.76 – CI95% 0.67-0.85) had the lowest chance of having undergone the molecular test.
Conclusion
Social, economic, contextual factors and the risk of aggravation of the disease were associated with carrying out the molecular test for COVID-19 in the state of Espírito Santo. Actions are needed to guarantee the access of the most vulnerable population to molecular testing.
Palavras-chave : COVID-19; COVID-19 nucleic acid testing; COVID-19 testing; cross-sectional studies.